Fluorenone-thiazolidine-4-one scaffolds as antidiabetic and antioxidant agents: design, synthesis, X-ray crystal structures, and binding and computational studies
Doddagaddavalli, Manasa A, Kalalbandi, Veerendra Kumar A, Naik, T. R. Ravi, Joshi, Shrinivas D, Seetharamappa, Jaldappagari
Published in New journal of chemistry (17.07.2023)
Published in New journal of chemistry (17.07.2023)
Get full text
Journal Article
Synthesis, crystal studies, anti-tuberculosis and cytotoxic studies of 1-[(2E)-3-phenylprop-2-enoyl]-1H-benzimidazole derivatives
Kalalbandi, Veerendra Kumar A., Seetharamappa, J., Katrahalli, Umesha, Bhat, Kishore G.
Published in European journal of medicinal chemistry (22.05.2014)
Published in European journal of medicinal chemistry (22.05.2014)
Get full text
Journal Article
Synthesis, characterization, crystallographic, binding, in silico and antidiabetic studies of novel 2,4-thiazolidinedione-phenothiazine molecular hybrids
Doddagaddavalli, Manasa A., Kalalbandi, Veerendra Kumar A., Seetharamappa, Jaldappagari
Published in Journal of molecular structure (15.03.2023)
Published in Journal of molecular structure (15.03.2023)
Get full text
Journal Article
STUDIES ON NOVEL METAL COMPLEXES OF COUMARIN SCHIFF BASE: SYNTHESIS, STABILITY CONSTANT, ANTIMICROBIAL AND ANTICANCER ACTIVITY
Vindhya R., Sharanakumar, T. M., A. Kalalbandi, Veerendra Kumar, Shashiraj, K. N., Nagarsha, K. M., Babu, H. M. Suresh, Suresh
Published in Rasāyan journal of chemistry (2024)
Published in Rasāyan journal of chemistry (2024)
Get full text
Journal Article
1-[(2E)-3-Phenylprop-2-enoyl]-1H-benzimidazoles as anticancer agents: synthesis, crystal structure analysis and binding studies of the most potent anticancer molecule with serum albuminElectronic supplementary information (ESI) available. CCDC 1018656. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5md00293a
Get full text
Journal Article
Synthesis, crystal studies and in vivo anti-hyperlipidemic activities of indole derivatives containing fluvastatin nucleusElectronic supplementary information (ESI) available. CCDC 1048304-1048307. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5ra02908b
Get full text
Journal Article